Stockreport

Groundbreaking HIV Prevention Shots Begin In Africa [Barron's]

Gilead Sciences, Inc.  (GILD) 
Last gilead sciences, inc. earnings: 4/30 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.gilead.com
PDF in the drug's first public rollouts in Africa, which has the world's highest HIV burden. Lenacapavir, which is taken twice a year, has been shown to reduce the risk of [Read more]